Published in Chest on September 01, 2007
Complications, consequences, and practice patterns of endobronchial ultrasound-guided transbronchial needle aspiration: Results of the AQuIRE registry. Chest (2013) 2.82
Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis. JAMA (2014) 2.20
Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol (2011) 2.16
Lung cancer: current diagnosis and treatment. Dtsch Arztebl Int (2009) 2.00
Nodal Upstaging During Lung Cancer Resection Is Associated With Surgical Approach. Ann Thorac Surg (2015) 1.91
Multi-modality mediastinal staging for lung cancer among medicare beneficiaries. J Thorac Oncol (2009) 1.76
Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial. Lancet Respir Med (2015) 1.67
Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest (2011) 1.54
Quality gaps and comparative effectiveness in lung cancer staging: the impact of test sequencing on outcomes. Chest (2013) 1.53
Mediastinal staging of NSCLC with endoscopic and endobronchial ultrasound. Nat Rev Clin Oncol (2009) 1.46
Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease. Ann Thorac Surg (2011) 1.18
Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients. Eur J Nucl Med Mol Imaging (2013) 1.08
The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours. Eur J Nucl Med Mol Imaging (2010) 1.00
Recent technological and application developments in computed tomography and magnetic resonance imaging for improved pulmonary nodule detection and lung cancer staging. J Magn Reson Imaging (2010) 0.98
Predicting non-small cell lung cancer prognosis by fully automated microscopic pathology image features. Nat Commun (2016) 0.98
Imaging of brain metastases. Surg Neurol Int (2013) 0.97
Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer. Ann Thorac Surg (2014) 0.97
Diagnostic efficacy of PET/CT plus brain MR imaging for detection of extrathoracic metastases in patients with lung adenocarcinoma. J Korean Med Sci (2009) 0.96
Lung cancer staging: clinical and radiologic perspectives. Semin Intervent Radiol (2013) 0.94
Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas. Lung Cancer (2011) 0.93
H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC. Oncotarget (2014) 0.90
Quality gaps and comparative effectiveness in lung cancer staging and diagnosis. Chest (2014) 0.89
18F-fluorodeoxyglucose positron emission tomography/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients. Interact Cardiovasc Thorac Surg (2012) 0.89
Surgery in 2013 and beyond. J Thorac Dis (2013) 0.88
Nodal stations and diagnostic performances of endobronchial ultrasound-guided transbronchial needle aspiration in patients with non-small cell lung cancer. J Korean Med Sci (2011) 0.88
How to scan who: the delicate balance between selecting the patient and selecting the imaging protocol. Eur J Nucl Med Mol Imaging (2017) 0.88
Invasive mediastinal staging of non-small-cell lung cancer: a clinical practice guideline. Curr Oncol (2011) 0.88
Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography. Cancer Imaging (2014) 0.87
Diagnostic value of endobronchial and endoscopic ultrasound-guided fine needle aspiration for accessible lung cancer lesions after non-diagnostic conventional techniques: a prospective study. BMC Cancer (2013) 0.87
Diagnostic imaging in the preoperative management of lung cancer. Surg Today (2013) 0.87
Impact of EBUS-TBNA on modalities for tissue acquisition in patients with lung cancer. QJM (2013) 0.87
Correlation between [¹⁸F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer. Eur J Nucl Med Mol Imaging (2013) 0.86
Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study. J Thorac Oncol (2011) 0.86
Image-derived biomarkers and multimodal imaging strategies for lung cancer management. Eur J Nucl Med Mol Imaging (2015) 0.86
Towards optimal pathologic staging of resectable non-small cell lung cancer. Transl Lung Cancer Res (2013) 0.83
Advantages of Combined PET-CT in Mediastinal Staging in Patients with Non-small Cell Lung Carcinoma. Acta Inform Med (2016) 0.82
Heterogeneity Analysis of (18)F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting. Nucl Med Mol Imaging (2013) 0.82
The role of convex probe endobronchial ultrasound guided transbronchial needle aspiration in the diagnosis of malignant mediastinal and hilar lymph nodes. Iran J Radiol (2012) 0.82
A randomized controlled trial evaluating airway inspection effectiveness during endobronchial ultrasound bronchoscopy. J Thorac Dis (2015) 0.82
False positive diagnosis of malignancy in a case of cryptogenic organising pneumonia presenting as a pulmonary mass with mediastinal nodes detected on fluorodeoxyglucose-positron emission tomography: a case report. J Med Case Rep (2009) 0.81
Advanced imaging (positron emission tomography and magnetic resonance imaging) and image-guided biopsy in initial staging and monitoring of therapy of lung cancer. Cancer J (2013) 0.81
Which subgroup of patients with pathologic N2 non-small cell lung cancer benefit from surgery? J Cancer Res Clin Oncol (2012) 0.81
Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer. Radiat Oncol (2014) 0.81
Determinants of practice patterns and quality gaps in lung cancer staging and diagnosis. Chest (2014) 0.80
Surgery following neoadjuvant chemotherapy for non-small-cell lung cancer patients with unexpected persistent pathological N2 disease. Mol Clin Oncol (2015) 0.80
Gaps in Guideline-Concordant Use of Diagnostic Tests Among Lung Cancer Patients. Ann Thorac Surg (2015) 0.79
Small vessel ischemic disease of the brain and brain metastases in lung cancer patients. PLoS One (2009) 0.79
Nomogram to Predict Occult N2 Lymph Nodes Metastases in Patients With Squamous Nonsmall Cell Lung Cancer. Medicine (Baltimore) (2015) 0.79
Lung cancer staging: the value of PET depends on the clinical setting. J Thorac Dis (2014) 0.78
Mediastinal staging in daily practice: endosonography, followed by cervical mediastinoscopy. Do we really need both? Interact Cardiovasc Thorac Surg (2013) 0.78
Thoroughness of mediastinal staging in stage IIIA non-small cell lung cancer. J Thorac Oncol (2012) 0.78
Role of positron emission tomography-computed tomography in non-small cell lung cancer. World J Methodol (2016) 0.78
Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a concise review. Transl Lung Cancer Res (2012) 0.77
Endobronchial Ultrasound Elastography for Diagnosing Mediastinal and Hilar Lymph Nodes. Chin Med J (Engl) (2015) 0.77
Dimerization of a phage-display selected peptide for imaging of αvβ6- integrin: two approaches to the multivalent effect. Theranostics (2014) 0.77
Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer. PLoS One (2015) 0.77
The use and misuse of positron emission tomography in lung cancer evaluation. Clin Chest Med (2011) 0.76
Optimal sequence of tests for the mediastinal staging of non-small cell lung cancer. BMC Med Inform Decis Mak (2016) 0.76
Quality indicators for the evaluation of patients with lung cancer. Chest (2014) 0.76
Appropriateness of imaging for lung cancer staging in a national cohort. J Clin Oncol (2014) 0.76
Facility-level analysis of PET scanning for staging among US veterans with non-small cell lung cancer. Chest (2014) 0.75
Clinical and surgical-pathological staging in early non-small cell lung cancer. Oncol Rev (2013) 0.75
A preliminary exploration of the intravoxel incoherent motion applied in the preoperative evaluation of mediastinal lymph node metastasis of lung cancer. J Thorac Dis (2017) 0.75
Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units. Sci Rep (2017) 0.75
Multiple right-sided pulmonary nodules: metastatic cancer or resectable early stage tumor? J Cardiothorac Surg (2011) 0.75
Impact of the introduction of EBUS on time to management decision, complications, and invasive modalities used to diagnose and stage lung cancer: a pragmatic pre-post study. BMC Cancer (2016) 0.75
Comparison of machine learning methods for classifying mediastinal lymph node metastasis of non-small cell lung cancer from (18)F-FDG PET/CT images. EJNMMI Res (2017) 0.75
Noninvasive Differential Diagnosis of Pulmonary Nodules Using the Standardized Uptake Value Index. Ann Thorac Cardiovasc Surg (2015) 0.75
Identification and Characterization of Potential Biomarkers by Quantitative Tissue Proteomics of Primary Lung Adenocarcinoma. Mol Cell Proteomics (2016) 0.75
Direct nodal sampling by echoendoscopy in lung cancer: the clinician's expectations: Direct nodal sampling by echoendoscopy in lung cancer. Insights Imaging (2011) 0.75
Budget impact from the incorporation of positron emission tomography - computed tomography for staging lung cancers. Rev Saude Publica (2015) 0.75
Endobronchial ultrasound: A new innovation in bronchoscopy. Lung India (2009) 0.75
Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography. Lung Cancer (Auckl) (2016) 0.75
A new needle on the block: EchoTip ProCore endobronchial ultrasound needle. Med Devices (Auckl) (2016) 0.75
Predicted extracapsular invasion of hilar lymph node metastasis by fusion positron emission tomography/computed tomography in patients with lung cancer. Mol Clin Oncol (2015) 0.75
Pulmonary function tests in the preoperative evaluation of lung cancer surgery candidates. A review of guidelines. Kardiochir Torakochirurgia Pol (2014) 0.75
Diagnostic yield and safety of C-TBNA in elderly patients with lung cancer. Open Med (Wars) (2016) 0.75
The imaging of small pulmonary nodules. Transl Lung Cancer Res (2017) 0.75
Increased x-ray attenuation in malignant vs. benign mediastinal nodes in an orthotopic model of lung cancer. Diagn Interv Radiol (2015) 0.75
Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis. Transl Lung Cancer Res (2015) 0.75
Single Posterior Approach for En-Bloc Resection and Stabilization for Locally Advanced Pancoast Tumors Involving the Spine: Single Centre Experience. Asian Spine J (2016) 0.75
Implementation of diffusion-weighted magnetic resonance imaging in target delineation of central lung cancer accompanied with atelectasis in precision radiotherapy. Oncol Lett (2017) 0.75
The impact on the prognosis of unsuspected N2 disease in non-small-cell lung cancer: indications for thorough mediastinal staging in the modern era. Surg Today (2016) 0.75
Ratio of Mediastinal Lymph Node SUV to Primary Tumor SUV in (18)F-FDG PET/CT for Nodal Staging in Non-Small-Cell Lung Cancer. Nucl Med Mol Imaging (2016) 0.75
A Prediction Model to Help with the Assessment of Adenopathy in Lung Cancer: HAL. Am J Respir Crit Care Med (2017) 0.75
The power of synergy in the mediastinal staging of lung cancer. Eur J Nucl Med Mol Imaging (2008) 0.75
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med (2008) 31.57
Preventing complications of central venous catheterization. N Engl J Med (2003) 16.18
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95
ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med (2003) 8.83
Benefits and harms of CT screening for lung cancer: a systematic review. JAMA (2012) 8.71
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.12
The new lung cancer staging system. Chest (2009) 6.30
An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med (2006) 5.29
Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.49
Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.29
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 4.01
Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 3.86
The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.74
Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. Chest (2003) 3.55
Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 3.46
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.36
Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients. Ann Surg (2006) 3.32
Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 3.31
Lung cancer incidence in never smokers. J Clin Oncol (2007) 3.20
Thoracoscopic lobectomy is associated with lower morbidity compared with thoracotomy. J Thorac Cardiovasc Surg (2009) 3.06
Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocol. Chest (2004) 2.89
An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units. Am J Respir Crit Care Med (2015) 2.86
Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.83
Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol (2009) 2.79
Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med (2011) 2.77
Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 2.74
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.72
Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.60
Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.56
Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J (2012) 2.55
Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 2.50
Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.47
Grades of recommendation for antithrombotic agents. Chest (2001) 2.44
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest (2014) 2.30
Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep (2003) 2.21
Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med (2009) 2.19
Lung cancer screening. Am J Respir Crit Care Med (2015) 2.14
The solitary pulmonary nodule. Chest (2003) 2.09
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06
Decision making in patients with pulmonary nodules. Am J Respir Crit Care Med (2011) 2.05
Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest (2007) 2.02
Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 2.00
Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza. Ann Intern Med (2009) 1.99
Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest (2007) 1.99
Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med (2001) 1.95
Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.94
Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review. Arch Neurol (2006) 1.92
Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.83
Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.81
What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest (2013) 1.79
Palliative and end-of-life care for patients with cardiopulmonary diseases: American College of Chest Physicians position statement. Chest (2005) 1.75
Associations between physical activity and 30-day readmission risk in chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 1.74
Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.74
Chemotherapeutic management of stage IV non-small cell lung cancer. Chest (2003) 1.74
Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest (2004) 1.73
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69
Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes (2005) 1.69
Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators. Cephalalgia (2012) 1.67
Treatment of non-small cell lung cancer, stage IV: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.66
Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 1.62
Executive summary: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest (2005) 1.61
Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation. Am J Respir Crit Care Med (2011) 1.58